Skip to main content

Gastroparesis Research Study

Diabetic Gastroparesis Studies/Disease Awareness information from Allergan Sales, LLC.

Below are links for further information on gastroparesis.

Purpose: the purpose of the study is to evaluate the safety and efficacy of relamorelin in Patients with Diabetic Gastroparesis.

Study population:

  • Males an females aged 18 and older with BMI >18.5kg/m
  • Type 1 Diabetes or Type 2 Diabetes for at least 5 years duration, with controlled and stable blood glucose levels and HbA1c   ≤11.0% at screening (visit 1)
  • Symptoms suggestive of Diabetic Gastroparesis (DG) for at least 3 months, (e.g…Nausea, abdominal pain, post-prandial fullness, bloating, vomiting and early satiety), with mechanical obstruction of the gastrointestinal (GI) tract as the cause of symptoms having been ruled out;
  • History of at least 4 vomiting episodes in the past month.

Study description: A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis.

Contact information: (855) 384-7884

Link to DG Explained: https://dgxplained.com/source/advocacy/

Link to Studykik: https://studykik.com/stomachstudy?utm=ag

Link to Clinical Trials explained:  https://clinicaltrialsxplained.com/